| Gadolinium-based MR Contrast Agents and Nephrogenic Systemic Fibrosis1 PH Kuo, E Kanal, AK Abu-Alfa, SE Cowper Radiology 242 (3), 647-649, 2007 | 764 | 2007 |
| Atmospheric carbon dioxide concentrations before 2.2 billion years ago R Rye, PH Kuo, HD Holland Nature 378 (6557), 603-605, 1995 | 430 | 1995 |
| Evaluations of extracellular pH within in vivo tumors using acidoCEST MRI LQ Chen, CM Howison, JJ Jeffery, IF Robey, PH Kuo, MD Pagel Magnetic resonance in medicine 72 (5), 1408-1417, 2014 | 221 | 2014 |
| EANM practice guideline/SNMMI procedure standard for dopaminergic imaging in Parkinsonian syndromes 1.0 S Morbelli, G Esposito, J Arbizu, H Barthel, R Boellaard, NI Bohnen, ... European journal of nuclear medicine and molecular imaging 47, 1885-1912, 2020 | 157 | 2020 |
| Clinical translation of tumor acidosis measurements with AcidoCEST MRI KM Jones, EA Randtke, ES Yoshimaru, CM Howison, P Chalasani, ... Molecular Imaging and Biology 19, 617-625, 2017 | 94 | 2017 |
| Gadolinium-containing MRI contrast agents: important variations on a theme for NSF PH Kuo Journal of the American College of Radiology 5 (1), 29-35, 2008 | 70 | 2008 |
| Stability and functionality of cysteine‐less FOF1 ATP synthase from Escherichia coli PH Kuo, CJ Ketchum, RK Nakamoto FEBS letters 426 (2), 217-220, 1998 | 62 | 1998 |
| Diagnostic performance of the visual reading of 123I-Ioflupane SPECT images with or without quantification in patients with movement disorders or dementia J Booij, J Dubroff, D Pryma, J Yu, R Agarwal, P Lakhani, PH Kuo Journal of nuclear medicine 58 (11), 1821-1826, 2017 | 60 | 2017 |
| FDG-PET/CT in the evaluation of cutaneous T-cell lymphoma PH Kuo, BL McClennan, K Carlson, LD Wilson, RL Edelson, PW Heald, ... Molecular Imaging and Biology 10, 74-81, 2008 | 59 | 2008 |
| [68Ga]Ga-PSMA-11 PET baseline imaging as a prognostic tool for clinical outcomes to [177Lu]Lu-PSMA-617 in patients with mCRPC: A VISION substudy. P Kuo, J Hesterman, K Rahbar, AT Kendi, XX Wei, B Fang, N Adra, ... Journal of Clinical Oncology 40 (16_suppl), 5002-5002, 2022 | 57 | 2022 |
| Nephrogenic systemic fibrosis and gadolinium exposure: association and lessons for idiopathic fibrosing disorders SE Cowper, PH Kuo, R Bucala Arthritis & Rheumatism: Official Journal of the American College of …, 2007 | 53 | 2007 |
| Molecular mechanisms of rotational catalysis in the F0F1 ATP synthase RK Nakamoto, CJ Ketchum, PH Kuo, YB Peskova, MK Al-Shawi Biochimica et Biophysica Acta (BBA)-Bioenergetics 1458 (2-3), 289-299, 2000 | 52 | 2000 |
| Signs and artifacts in amyloid PET TF Lundeen, JP Seibyl, MF Covington, N Eshghi, PH Kuo Radiographics 38 (7), 2123-2133, 2018 | 46 | 2018 |
| Gadolinium‐containing magnetic resonance image contrast agent promotes fibrocyte differentiation V Vakil, JJ Sung, M Piecychna, JR Crawford, P Kuo, AK Abu‐Alfa, ... Journal of Magnetic Resonance Imaging: An Official Journal of the …, 2009 | 43 | 2009 |
| Meningeal lymphatic vessel flow runs countercurrent to venous flow in the superior sagittal sinus of the human brain PH Kuo, C Stuehm, S Squire, K Johnson Tomography 4 (3), 99-104, 2018 | 41 | 2018 |
| 18F-FDG PET/CT can predict development of thyroiditis due to immunotherapy for lung cancer N Eshghi, LL Garland, E Nia, R Betancourt, E Krupinski, PH Kuo Journal of nuclear medicine technology 46 (3), 260-264, 2018 | 41 | 2018 |
| Clinical utility of DaTscan in patients with suspected Parkinsonian syndrome: a systematic review and meta-analysis D Bega, PH Kuo, A Chalkidou, MT Grzeda, T Macmillan, C Brand, ... npj Parkinson's Disease 7 (1), 43, 2021 | 40 | 2021 |
| Why we did what we did: PSMA PET/CT selection criteria for the VISION trial PH Kuo, T Benson, R Messmann, M Groaning Journal of Nuclear Medicine 63 (6), 816-818, 2022 | 33 | 2022 |
| Nephrogenic systemic fibrosis JC Weinreb, PH Kuo Magnetic resonance imaging clinics of North America 17 (1), 159-167, 2009 | 33 | 2009 |
| Semiquantitative analysis of dopamine transporter scans in patients with Parkinson disease S Tinaz, C Chow, PH Kuo, EA Krupinski, H Blumenfeld, ED Louis, G Zubal Clinical nuclear medicine 43 (1), e1-e7, 2018 | 31 | 2018 |
